The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

Plc - Final Results and Notice of AGM PR Newswire LONDON, United Kingdom, May 27 27 May 20244basebio plc("4basebio", the "Company" or the "Group")Final Results and ...

One of the unmet needs in this field is the lack of a robust, sensitive, and multiplexed method for EV mRNA profiling. We established a new protocol using the NanoString low RNA input nCounter assay ...